Find Expert Doctors on Kidney Neoplasms1,861 top medical experts on Kidney Neoplasms across 61 countries and 41 U.S. states, including 1,761 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Kidney Neoplasms: Tumors or cancers of the kidney.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Kidney Diseases (3,539), Urologic Neoplasms (3,165) and Narrower Categories: Mesoblastic Nephroma (426), Renal Cell Carcinoma (4,911), Wilms Tumor (1,685).
- Clinical Trials
: at least 755 including 39 Active, 367 Completed, 126 Recruiting - Synonyms: Cancer of Kidney, Kidney Cancer, Renal Cancer
- Choueiri, Toni K Medical Oncology
Dana-Farber Cancer Institute, The Lank Center for Genitourinary Oncology, Boston, MA, USA. Top HospitalDisclosed payments in 2021 from 12 biomedical companies, totalling $27,297.2, including $14,250 from Merck Sharp & Dohme CorporationSubjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Vascular Endothelial Growth Factor A; Protein Kinase InhibitorsCategories: Drug Therapy; Therapeutic Use; Genetics; Administration & Dosage; Antagonists & Inhibitors; Therapy - Motzer, Robert J Medical Oncology Memorial Sloan Kettering Cancer Center, New York, NY, USA. Top HospitalDisclosed payments in 2021 from 21 biomedical companies, totalling $29,011.95, including $11,146.74 from Merck Sharp & Dohme CorporationSubjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Indoles; PyrrolesCategories: Therapeutic Use; Drug Therapy; Genetics; Administration & Dosage; Mortality; Pathology
- Rini, Brian I Hematology & Oncology Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Top HospitalMedical school: Ohio State University College of Medicine (MD, 1995)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 73/100Disclosed payments in 2021 from 40 biomedical companies, totalling $98,013.85, including $42,466.27 from Merck Sharp & Dohme CorporationSubjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Indoles; PyrrolesCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Pathology; Metabolism; Adverse Effects
- Escudier, Bernard J Department of Medical Oncology, Institut Gustave Roussy, CEDEX, 94805 Villejuif, France.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Indoles; PyrrolesCategories: Drug Therapy; Therapeutic Use; Therapy; Administration & Dosage; Adverse Effects; Pathology
- Powles, Thomas Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Indoles; PyrrolesCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Adverse Effects; Therapy; Surgery
- McDermott, David F Beth Israel Deaconess Medical Center, Boston, MA, USA. Top HospitalSubjects: Carcinoma, Renal Cell; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Antibodies, Monoclonal; Antineoplastic Agents, ImmunologicalCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Antagonists & Inhibitors; Genetics; Immunology
- Plimack, Elizabeth R Medical Oncology Fox Chase Cancer Center, Philadelphia, PA, USA.Medical school: New York Medical College (MD, 2002)Medicare AcceptedDisclosed payments in 2021 from 19 biomedical companies, totalling $34,444, including $8,080 from Merck Sharp & Dohme CorporationSubjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; SunitinibCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Therapy; Pathology; Immunology
- Porta, Camillo Division of Medical Oncology, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy; Chair of Oncology, Interdisciplinary Department of Medicine, University of Bari A. Moro, Bari, Italy.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Indoles; Protein Kinase InhibitorsCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Pathology; Therapy; Adverse Effects
- Donskov, Frede N Aarhus University Hospital, Aarhus, Denmark.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Angiogenesis Inhibitors; Molecular Targeted TherapyCategories: Drug Therapy; Therapeutic Use; Pathology; Mortality; Administration & Dosage; Adverse Effects
- Larkin, James M G Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Indoles; PyrrolesCategories: Drug Therapy; Therapeutic Use; Genetics; Pathology; Administration & Dosage; Immunology
- Atkins, Michael B Medical Oncology Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.Medical school: Tufts University School of Medicine (MD, 1980)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 100/100Disclosed payments in 2021 from 33 biomedical companies, totalling $53,596.94, including $12,392.7 from F. Hoffmann-La Roche AGSubjects: Carcinoma, Renal Cell; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Antineoplastic Agents, Immunological; Angiogenesis InhibitorsCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Pathology; Metabolism; Therapy
- Hammers, Hans-Joerg Division of Hematology and Oncology, UT Southwestern Kidney Cancer Program, Dallas, Texas.Subjects: Carcinoma, Renal Cell; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antibodies, MonoclonalCategories: Therapeutic Use; Drug Therapy; Administration & Dosage; Therapy; Metabolism; Methods
- Gurney, Howard Department of Medical Oncology, Westmead Hospital and Macquarie University, Westmead, New South Wales, Australia.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents, ImmunologicalCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Antagonists & Inhibitors; Methods; Pathology
- Kollmannsberger, Christian K Department of Medical Oncology, BC Cancer Vancouver Centre, Vancouver, BC, V5Z 4E6, Canada.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Vascular Endothelial Growth Factor A; Antineoplastic Combined Chemotherapy Protocols; SunitinibCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Mortality; Pathology; Antagonists & Inhibitors
- Tannir, Nizar M Medical Oncology Department of Genitourinary Medical Oncology, The University of Texas MD Anderson, Houston, TX, USA.Disclosed payments in 2021 from 24 biomedical companies, totalling $37,540.55, including $21,608.35 from Eisai Inc.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Indoles; PyrrolesCategories: Drug Therapy; Therapeutic Use; Genetics; Administration & Dosage; Pathology; Surgery
- Hutson, Thomas E Medical Oncology Texas A&M University College of Medicine, Bryan, Texas, USA.Medical school: Ohio University, College of Osteopathic Medicine (DO, 1997)Medicare AcceptedDisclosed payments in 2021 from 114 biomedical companies, totalling $181,603.93, including $29,174.96 from Exelixis Inc.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Indoles; Pyrroles; Protein Kinase InhibitorsCategories: Therapeutic Use; Drug Therapy; Administration & Dosage; Antagonists & Inhibitors; Analogs & Derivatives; Blood
- George, Saby Medical Oncology Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, 14203, USA. Electronic address: .Disclosed payments in 2021 from 26 biomedical companies, totalling $38,241.03, including $13,774.68 from EMD Serono, Inc.Subjects: Carcinoma, Renal Cell; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Antibodies, Monoclonal; Antineoplastic Agents, ImmunologicalCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Antagonists & Inhibitors; Diagnosis; Drug Effects
- Melichar, Bohuslav Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic.Subjects: Carcinoma, Renal Cell; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Protein Kinase Inhibitors; Antibodies, Monoclonal, HumanizedCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Pathology; Secondary; Therapy
- Ravaud, Alain Centre Hospitalier Universitaire CHU de Bordeaux, service doncologie médicale, Bordeaux, France.Subjects: Carcinoma, Renal Cell; Antineoplastic Agents; Indoles; Protein Kinase Inhibitors; PyrrolesCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Therapy; Methods; Adverse Effects
- Reuter, Victor E Anatomic Pathology Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Top HospitalDisclosed payments from biomedical company (Janssen Research & Development, LLC) in 2021 for $1,860Subjects: Carcinoma, Renal Cell; Biomarkers, Tumor; Mutation; Carcinoma, Papillary; Adenocarcinoma, MucinousCategories: Genetics; Pathology; Metabolism; Diagnosis; Classification; Methods
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.